1. Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism
   Domenico Conza et al, 2021, Cells CrossRef
2. Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells
   Dong Hoon Suh et al, 2020, Journal of Clinical Medicine CrossRef
3. Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects
   Sara Baldassari et al, 2018, Scientific Reports CrossRef
4. Linking type 2 diabetes and gynecological cancer: an introductory overview
   Emanuela Anastasi et al, 2018, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef
5. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus
   Faustino R. Perez-Lopez et al, 2017, Maturitas CrossRef
6. Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
   Sarah J. Kitson et al, 2019, Cancers CrossRef
7. A guide for endometrial cancer cell lines functional assays using the measurements of electronic impedance
   Joanna Kozak et al, 2018, Cytotechnology CrossRef
8. Metformin as a Therapeutic Target in Endometrial Cancers
   Teresa Y. Lee et al, 2018, Frontiers in Oncology CrossRef
9. Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells
   Carsten Lange et al, 2023, Heliyon CrossRef
10. Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer
    Melinda S. Yates et al, 2018, Cancer Prevention Research CrossRef
11. Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength
    M. Imran et al, 2023, Canadian Journal of Physiology and Pharmacology CrossRef
12. PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
    Sarah J. Kitson et al, 2019, Clinical Cancer Research CrossRef
13. Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
    Vanitha N. Sivalingam et al, 2020, British Journal of Cancer CrossRef